Element Capital Management LLC Takes $5.09 Million Position in HCA Healthcare, Inc. $HCA

Element Capital Management LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, Holdings Channel reports. The fund bought 11,934 shares of the company’s stock, valued at approximately $5,086,000. HCA Healthcare accounts for 7.2% of Element Capital Management LLC’s holdings, making the stock its 6th biggest position.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Clearstead Trust LLC increased its position in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at approximately $40,000. Compound Global Advisors LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth approximately $44,000. Finally, True Wealth Design LLC raised its holdings in HCA Healthcare by 179.5% in the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after acquiring an additional 70 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares of the company’s stock, valued at $22,411,395. The trade was a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Up 0.2%

Shares of HCA Healthcare stock opened at $533.39 on Friday. The stock has a market capitalization of $119.28 billion, a price-to-earnings ratio of 18.79, a PEG ratio of 1.64 and a beta of 1.34. The business’s 50 day simple moving average is $507.05 and its 200-day simple moving average is $470.03. HCA Healthcare, Inc. has a twelve month low of $313.21 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.15%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group boosted their target price on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Leerink Partners boosted their price objective on HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a research report on Monday, February 9th. Argus upped their price target on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Finally, TD Cowen boosted their target price on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, March 10th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $537.73.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.